Augmedix Inc (NAS:AUGX)
$ 1.16 -0.05 (-4.13%) Market Cap: 56.80 Mil Enterprise Value: 47.64 Mil PE Ratio: 0 PB Ratio: 3.14 GF Score: 44/100

Q4 2023 Augmedix Inc Earnings Call Transcript

Mar 18, 2024 / 08:30PM GMT
Release Date Price: $3.33 (+4.06%)
Operator

Yes, greetings, and welcome to all Augmedix's fourth quarter 2023 earnings conference call. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentation. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce Matt Chesler, Investor Relations. Thank you. You may begin.

Matt Chesler
Augmedix, Inc. - IR

Thank you, operator. Joining me today are Manny Krakaris, Chief Executive Officer of Augmedix; and Paul Ginocchio, Chief Financial Officer. This afternoon, we released financial results for the quarter ended December 31, 2023. We've posted a copy of the press release and an investor presentation on our website at Augmenix.com. We'll begin our call with prepared remarks to be followed by a Q&A session. This call is also being simulcast and will be archived on our website.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot